Breaking News
Get 50% Off 0
📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-Earnings Read more
Close

Novo Nordisk A/S (NVO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Novo Nordisk ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
131.54 +1.55    +1.19%
20/07 - Closed. Currency in USD ( Disclaimer )
After Hours
131.47
-0.07
-0.05%
9:57:23 - Real-time Data
  • Volume: 4,319,544
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 131.30 - 133.50
Type:  Equity
Market:  United States
Novo Nordisk ADR 131.54 +1.55 +1.19%

NVO Income Statement

 
Featured here, the Income Statement (earnings report) for Novo Nordisk A/S, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Income Statement
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Revenue 65349 65863 58731 54300
Revenue 65349 65863 58731 54300
Other Revenue, Total - - - -
Cost of Revenue, Total 9916 10014 9713 7856
Gross Profit 55433 55849 49018 46444
Total Operating Expenses 33503 37683 31818 30412
Selling/General/Admin. Expenses, Total 14413 18626 14075 15414
Research & Development 8606 9046 8128 7127
Depreciation / Amortization 2914 -6421 2525 2177
Interest Expense (Income) - Net Operating - -542 - -
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -2346 6960 -2623 -2162
Operating Income 31846 28180 26913 23888
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - 37 - -
Other, Net -72 523 -1150 -366
Net Income Before Taxes 31918 27620 28063 24254
Provision for Income Taxes 6511 5657 5585 4826
Net Income After Taxes 25407 21963 22478 19428
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 25407 21963 22478 19428
Total Extraordinary Items - - - -
Net Income 25407 21963 22478 19428
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 25407 21963 22478 19428
Dilution Adjustment 14.56 -13.24 33 -0.719
Diluted Net Income 25392.44 21976.24 22445 19428.72
Diluted Weighted Average Shares 4470.5 4477.4 4489 4502.6
Diluted EPS Excluding Extraordinary Items 5.68 4.91 5 4.32
DPS - Common Stock Primary Issue - 6.4 - 3
Diluted Normalized EPS 4.46 4.05 3.91 3.37
* In Millions of DKK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVO Comments

Write your thoughts about Novo Nordisk A/S
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mac Dre
Mac Dre Oct 14, 2023 6:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
we're going to the moon 🌙 🌚 ✨️
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email